Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Cell viabilities and biodegradation rates of DNA/protamine complexes with two different molecular weights of DNA.

Mori N, Ohno J, Sakagami R, Hayakawa T, Fukushima T.

J Biomed Mater Res B Appl Biomater. 2013 Jul;101(5):743-51. doi: 10.1002/jbm.b.32877. Epub 2013 Jan 29.

PMID:
23359567
2.

Polycationic protamine for water-insoluble complex formation with DNA.

Fukushima T, Ohno J, Hayakawa T, Imayoshi R, Kawaguchi M, Doi Y, Kanaya K, Mitarai M.

Dent Mater J. 2010 Oct;29(5):529-35. Epub 2010 Aug 20.

3.

Ternary complex of plasmid DNA with protamine and γ-polyglutamic acid for biocompatible gene delivery system.

Kanda K, Kodama Y, Kurosaki T, Imamura M, Nakagawa H, Muro T, Higuchi N, Nakamura T, Kitahara T, Honda M, Sasaki H.

Biol Pharm Bull. 2013;36(11):1794-9.

4.

Osteogenic potential for replacing cells in rat cranial defects implanted with a DNA/protamine complex paste.

Toda M, Ohno J, Shinozaki Y, Ozaki M, Fukushima T.

Bone. 2014 Oct;67:237-45. doi: 10.1016/j.bone.2014.07.018. Epub 2014 Jul 19.

PMID:
25051019
5.

Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization.

Nakamura S, Kishimoto S, Nakamura S, Nambu M, Fujita M, Tanaka Y, Mori Y, Tagawa M, Maehara T, Ishihara M.

J Biomed Mater Res A. 2010 Mar 15;92(4):1614-22. doi: 10.1002/jbm.a.32506.

PMID:
19437440
6.

DNA/protamine complex paste for an injectable dental material.

Fukushima T, Ohno J, Imayoshi R, Mori N, Sakagami R, Mitarai M, Hayakawa T.

J Mater Sci Mater Med. 2011 Dec;22(12):2607-15. doi: 10.1007/s10856-011-4446-9. Epub 2011 Sep 16.

PMID:
21922330
7.

Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study.

Park YJ, Liang JF, Ko KS, Kim SW, Yang VC.

J Gene Med. 2003 Aug;5(8):700-11.

8.

Single molecule studies of DNA-protamine interactions.

Cree LH, Balhorn R, Brewer LR.

Protein Pept Lett. 2011 Aug;18(8):802-10.

PMID:
21443493
9.

Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine.

Puras G, Martínez-Navarrete G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Avilés-Trigueros M, Fernández E, Pedraz JL.

Mol Pharm. 2015 Oct 5;12(10):3658-71. doi: 10.1021/acs.molpharmaceut.5b00422. Epub 2015 Sep 11.

PMID:
26334586
10.

Synthesis and characterization of stearyl protamine and investigation of their complexes with DNA for gene delivery.

Liu J, Guo S, Li Z, Liu L, Gu J.

Colloids Surf B Biointerfaces. 2009 Oct 1;73(1):36-41. doi: 10.1016/j.colsurfb.2009.04.026. Epub 2009 May 4.

PMID:
19481426
11.

In vivo biodegradability and biocompatibility evaluation of novel alanine ester based polyphosphazenes in a rat model.

Sethuraman S, Nair LS, El-Amin S, Farrar R, Nguyen MT, Singh A, Allcock HR, Greish YE, Brown PW, Laurencin CT.

J Biomed Mater Res A. 2006 Jun 15;77(4):679-87.

PMID:
16514601
12.

Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.

Nakamura S, Kanatani Y, Kishimoto S, Nakamura S, Ohno C, Horio T, Masanori F, Hattori H, Tanaka Y, Kiyosawa T, Maehara T, Ishihara M.

J Biomed Mater Res A. 2009 Dec;91(3):814-23. doi: 10.1002/jbm.a.32265.

PMID:
19051304
13.

Improved gene expression using low molecular weight peptides produced from protamine sulfate.

Kharidia R, Friedman KA, Liang JF.

Biochemistry (Mosc). 2008 Oct;73(10):1162-8.

PMID:
18991564
14.

A thermosensitive low molecular weight hydrogel as scaffold for tissue engineering.

Ziane S, Schlaubitz S, Miraux S, Patwa A, Lalande C, Bilem I, Lepreux S, Rousseau B, Le Meins JF, Latxague L, Barthélémy P, Chassande O.

Eur Cell Mater. 2012 Feb 23;23:147-60; discussion 160.

15.

Protein binding regions in the mouse and rat protamine-2 genes.

Johnson PA, Bunick D, Hecht NB.

Biol Reprod. 1991 Jan;44(1):127-34.

PMID:
2015343
16.

pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.

Vighi E, Ruozi B, Montanari M, Battini R, Leo E.

Int J Pharm. 2010 Apr 15;389(1-2):254-61. doi: 10.1016/j.ijpharm.2010.01.030. Epub 2010 Jan 25.

PMID:
20100555
17.
18.

AFM analysis of DNA-protamine complexes bound to mica.

Allen MJ, Bradbury EM, Balhorn R.

Nucleic Acids Res. 1997 Jun 1;25(11):2221-6.

19.

Effect of protamine on the solubility and deamidation of human growth hormone.

Ablinger E, Wegscheider S, Keller W, Prassl R, Zimmer A.

Int J Pharm. 2012 May 10;427(2):209-16. doi: 10.1016/j.ijpharm.2012.01.061. Epub 2012 Feb 8.

PMID:
22342332
20.

Low molecular weight protamine: a potential nontoxic heparin antagonist.

Byun Y, Singh VK, Yang VC.

Thromb Res. 1999 Apr 1;94(1):53-61.

PMID:
10213181

Supplemental Content

Support Center